| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 35 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 26 |
| 2 | TACROLIMUS OINTMENT 0.1% | 26 |
| 3 | BASILIXIMAB | 19 |
| 4 | ETHIODIZED OIL | 18 |
| 5 | OXALIPLATIN | 17 |
| 6 | MYCOPHENOLATE MOFETIL | 14 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 14 |
| 8 | PREDNISONE | 13 |
| 9 | CYCLOSPORINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHIODIZED OIL | 18 | 0.0139 |
| 1 | FLOXURIDINE | 2 | 0.0116 |
| 2 | PORFIMER SODIUM | 1 | 0.0029 |
| 3 | BASILIXIMAB | 19 | 0.0016 |
| 4 | TIGECYCLINE | 7 | 0.0011 |
| 5 | MICAFUNGIN SODIUM | 7 | 0.0011 |
| 6 | NORETHINDRONE AND ETHINYL ESTRADIOL | 1 | 0.0009 |
| 7 | ANIDULAFUNGIN | 1 | 0.0006 |
| 8 | MITOMYCIN | 2 | 0.0005 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 4 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 8 | 0.0010 |
| 1 | Tetracycline-class Antibacterial [EPC] | 7 | 0.0009 |
| 2 | Radiographic Contrast Agent [EPC] | 20 | 0.0008 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 9 | 0.0004 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 26 | 0.0001 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |